These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10101621)

  • 1. Acute subjective effects of dynorphin A(1-13) infusion in normal healthy subjects.
    King AC; Ho A; Schluger J; Borg L; Kreek MJ
    Drug Alcohol Depend; 1999 Mar; 54(1):87-90. PubMed ID: 10101621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressed prolactin response to dynorphin A1-13 in methadone-maintained versus control subjects.
    Bart G; Borg L; Schluger JH; Green M; Ho A; Kreek MJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):581-7. PubMed ID: 12730354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [D-Ala2, (F5) Phe4]-dynorphin 1-13-NH2 (DAFPHEDYN): a potent analog of dynorphin 1-13.
    Walker JM; Coy DH; Young EA; Baldrighi G; Siegel SF; Bowen WD; Akil H
    Peptides; 1987; 8(5):811-7. PubMed ID: 2893357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dynorphin A(1-13) on opiate withdrawal in humans.
    Specker S; Wananukul W; Hatsukami D; Nolin K; Hooke L; Kreek MJ; Pentel PR
    Psychopharmacology (Berl); 1998 Jun; 137(4):326-32. PubMed ID: 9676891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynorphin A (1-13) and responsiveness of the newborn rat to a surrogate nipple: immediate behavioral consequences and reinforcement effects in conditioning.
    Petrov ES; Nizhnikov ME; Varlinskaya EI; Spear NE
    Behav Brain Res; 2006 Jun; 170(1):1-14. PubMed ID: 16621051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynorphin-A-(1-13) antagonizes morphine analgesia in the brain and potentiates morphine analgesia in the spinal cord.
    Ren MF; Lu CH; Han JS
    Peptides; 1985; 6(6):1015-20. PubMed ID: 2871545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynorphin A-(1-13) and (2-13) improve beta-amyloid peptide-induced amnesia in mice.
    Hiramatsu M; Inoue K; Kameyama T
    Neuroreport; 2000 Feb; 11(3):431-5. PubMed ID: 10718289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual effects of dynorphin-(1-13) on cholinergic and substance P-ergic transmissions in the rabbit iris sphincter muscle.
    Ueda N; Muramatsu I; Fujiwara M
    J Pharmacol Exp Ther; 1985 Feb; 232(2):545-50. PubMed ID: 2578568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aquaretic effect of the stable dynorphin-A analog E2078 in the human.
    Ohnishi A; Mihara M; Yasuda S; Tomono Y; Hasegawa J; Tanaka T
    J Pharmacol Exp Ther; 1994 Jul; 270(1):342-7. PubMed ID: 7913498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dynorphin A (1-13) on carbon monoxide-induced delayed amnesia in mice.
    Hiramatsu M; Sasaki M; Nabeshima T; Kameyama T
    Pharmacol Biochem Behav; 1997 Jan; 56(1):73-9. PubMed ID: 8981612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classical conditioning in the fetal rat: reinforcing properties of dynorphin A (1-13).
    Varlinskaya EI; Petrov ES; Smotherman WP
    Behav Neurosci; 1996 Feb; 110(1):154-67. PubMed ID: 8652064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dynorphin A(1-13) and of fragments of beta-endorphin on blood pressure and heart rate of anesthetized rats.
    van Giersbergen PL; de Lang H; de Jong W
    Can J Physiol Pharmacol; 1991 Mar; 69(3):327-33. PubMed ID: 1676337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pharmacology of the opioid neuropeptide dynorphin A(1-13).
    Greenwald MK; Stitzer ML; Haberny KA
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1154-63. PubMed ID: 9190848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice.
    Ukai M; Itoh J; Kobayashi T; Shinkai N; Kameyama T
    Behav Brain Res; 1997 Feb; 83(1-2):169-72. PubMed ID: 9062678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidimensional behavioral analyses show dynorphin A-(1-13) modulation of methamphetamine-induced behaviors in mice.
    Ukai M; Toyoshi T; Kameyama T
    Eur J Pharmacol; 1992 Nov; 222(1):7-12. PubMed ID: 1361442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic responses of conscious rats following intrathecal injections of prodynorphin-derived opioids: independence of action of intrathecal arginine vasopressin.
    Thornhill JA; Pittman QJ
    Can J Physiol Pharmacol; 1990 Feb; 68(2):174-82. PubMed ID: 1968777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kappa agonists inhibit gastric emptying but not acid secretion in rhesus monkeys.
    Touzeau PL; Shea-Donohue T
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1010-6. PubMed ID: 1972746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist.
    Hiramatsu M; Murasawa H; Mori H; Kameyama T
    Br J Pharmacol; 1998 Mar; 123(5):920-6. PubMed ID: 9535021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin A (1-13), microinjected into the preoptic area, stimulates water intake in rats.
    Shimizu H; Shimomura Y; Negishi M; Kobayashi I; Kobayashi S
    Life Sci; 1989; 45(1):25-30. PubMed ID: 2568571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.